TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
Authors
Keywords
-
Journal
MODERN PATHOLOGY
Volume 28, Issue 2, Pages 177-186
Publisher
Springer Nature
Online
2014-08-01
DOI
10.1038/modpathol.2014.94
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TERT promoter mutations rather than methylation are the main mechanism for TERT upregulation in adult gliomas
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- TERT promoter mutations in primary and secondary glioblastomas
- (2013) Naosuke Nonoguchi et al. ACTA NEUROPATHOLOGICA
- Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss
- (2013) Hideyuki Arita et al. ACTA NEUROPATHOLOGICA
- Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system
- (2013) Christian Koelsche et al. ACTA NEUROPATHOLOGICA
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma
- (2013) Marc Remke et al. ACTA NEUROPATHOLOGICA
- Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study
- (2013) Pedro Castelo-Branco et al. LANCET ONCOLOGY
- Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors
- (2013) Aden Ka-Yin Chan et al. MODERN PATHOLOGY
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TERT Promoter Mutations in Familial and Sporadic Melanoma
- (2013) S. Horn et al. SCIENCE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
- (2012) Gregory Cairncross et al. JOURNAL OF CLINICAL ONCOLOGY
- Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951
- (2012) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology
- (2010) David Capper et al. ACTA NEUROPATHOLOGICA
- Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician’s perspective
- (2010) Martin J. van den Bent ACTA NEUROPATHOLOGICA
- Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis
- (2010) Philippe Metellus et al. ACTA NEUROPATHOLOGICA
- hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
- (2010) Jillian de Wilde et al. BMC CANCER
- Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosis
- (2009) Sandra Camelo-Piragua et al. ACTA NEUROPATHOLOGICA
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gliomas With 1p/19q Codeletion:a.k.a. Oligodendroglioma
- (2008) Gregory Cairncross et al. CANCER JOURNAL
- Oligodendroglioma
- (2008) Martin J. Van den Bent et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started